These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26842295)

  • 1. Methadone for prisoners--Authors' reply.
    Rich JD; McKenzie M; Larney S; Noska A; Clark J
    Lancet; 2016 Jan; 387(10015):225. PubMed ID: 26842295
    [No Abstract]   [Full Text] [Related]  

  • 2. Methadone for prisoners.
    Anghelescu I
    Lancet; 2016 Jan; 387(10015):224-5. PubMed ID: 26842293
    [No Abstract]   [Full Text] [Related]  

  • 3. Methadone for prisoners.
    D'Hotman D; Pugh J; Douglas T
    Lancet; 2016 Jan; 387(10015):224. PubMed ID: 26842294
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal from methadone in US prisons: cruel and unusual?
    Milloy MJ; Wood E
    Lancet; 2015 Jul; 386(9991):316-8. PubMed ID: 26028122
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving methadone maintenance therapy for prisoner populations.
    Wright N; Hearty P
    Evid Based Ment Health; 2015 Nov; 18(4):e12. PubMed ID: 26424864
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on Nosyk et al. (2012): detoxification from methadone maintenance therapy: how important is the exact technique that is used?
    Day E
    Addiction; 2012 Sep; 107(9):1630-1. PubMed ID: 22861675
    [No Abstract]   [Full Text] [Related]  

  • 7. Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?
    Bhupal HK
    Br J Gen Pract; 2012 Feb; 62(595):68-9. PubMed ID: 22520768
    [No Abstract]   [Full Text] [Related]  

  • 8. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Police interference with methadone treatment in Bangkok, Thailand.
    Hayashi K; Ti L; Kaplan K; Suwannawong P; Wood E; Kerr T
    Int J Drug Policy; 2015 Jan; 26(1):112-5. PubMed ID: 25239286
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors associated with methadone treatment among injection drug users in Bangkok, Thailand.
    Fairbairn N; Hayashi K; Kaplan K; Suwannawong P; Qi J; Wood E; Kerr T
    J Subst Abuse Treat; 2012 Jul; 43(1):108-13. PubMed ID: 22154035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.
    Fu JJ; Zaller ND; Yokell MA; Bazazi AR; Rich JD
    J Subst Abuse Treat; 2013; 44(5):502-5. PubMed ID: 23433809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of methadone initiation prior to release from incarceration.
    McKenzie M; Zaller N; Dickman SL; Green TC; Parihk A; Friedmann PD; Rich JD
    Subst Abus; 2012; 33(1):19-29. PubMed ID: 22263710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
    Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Execution of control among 'non-compliant', imprisoned individuals in opioid maintenance treatment.
    Havnes IA; Clausen T; Middelthon AL
    Int J Drug Policy; 2014 May; 25(3):480-5. PubMed ID: 24594221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communicating risk in the context of methadone formulation changes: A qualitative study of overdose warning posters in Vancouver, Canada.
    Markwick N; McNeil R; Anderson S; Small W; Kerr T
    Int J Drug Policy; 2016 Jan; 27():178-81. PubMed ID: 26644025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improve the benefit/risk balance of methadone by respecting its pharmacological specificities].
    Frauger E; Fouilhé Sam-Laï N; Mallaret M; Micallef J;
    Therapie; 2019 Jun; 74(3):383-388. PubMed ID: 31178032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid substitution: improving cost-efficiency.
    Sullivan S
    Bull World Health Organ; 2013 Feb; 91(2):83. PubMed ID: 23554517
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid maintenance in European prisons: is the treatment gap closing?
    Hedrich D; Farrell M
    Addiction; 2012 Mar; 107(3):461-3. PubMed ID: 22313099
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.